Clinical Trial Update: FluoroAv45 Imaging Research-in Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 imaging trial using FluoroAv45 in Alzheimer's disease and mild cognitive impairment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• FluoroAv45

Snippet

Sponsor: University Hospital, Tours | Conditions: Alzheimer's Disease, Mild Cognitive Impairment | Phase 2 | Status: COMPLETED